Ticks infest a variety of animal species and transmit pathogens causing disease in both humans and animals worldwide. Tick-host-pathogen interactions have evolved through dynamic processes that accommodated the genetic traits of the hosts, pathogens transmitted and the vector tick species that mediate their development and survival. New approaches for tick control are dependent on defining molecular interactions between hosts, ticks and pathogens to allow for discovery of key molecules that could be tested in vaccines or new generation therapeutics for intervention of tick-pathogen cycles. Currently, tick vaccines constitute an effective and environmentally sound approach for the control of ticks and the transmission of the associated tick-borne diseases. New candidate protective antigens will most likely be identified by focusing on proteins with relevant biological function in the feeding, reproduction, development, immune response, subversion of host immunity of the tick vector and/or molecules vital for pathogen infection and transmission. This review addresses different approaches and strategies used for the discovery of protective antigens, including focusing on relevant tick biological functions and proteins, reverse genetics, vaccinomics and tick protein evolution and interactomics. New and improved tick vaccines will most likely contain multiple antigens to control tick infestations and pathogen infection and transmission.
INTRODUCTION
Diseases caused by arthropod-borne pathogens account for over 20% of all emerging infectious diseases recorded between 1940 and 2004 (1) . Ticks are considered to be second worldwide to mosquitoes as vectors of human diseases and the most important vectors of diseases that affect animal health worldwide, with the largest effect on the cattle industry (2, 3) . It is therefore evident that ticks and their associated transmitted pathogens constitute a growing burden for human and animal health worldwide (4, 5) . Tick control has been primarily based on the use of chemical acaricides resulting in partial efficacy and enhanced selection of resistant tick populations (6) . Therefore, new approaches are needed for effective control of ticks and their associated tick-borne diseases, of which vaccines appear to be an effective and environmentally sound option (6) .
The only commercially available vaccines against ectoparasites were developed and registered in the early 1990s for the control of cattle tick infestations (7) . These vaccines are based on recombinant Rhipicephalus microplus BM86/BM95 antigens and demonstrated the important advantages of being a cost-effective and environmentally friendly alternative with a dual effect of reducing tick infestations and preventing ticks from transmitting disease-causing pathogens (7) . The protective mechanism characterized for BM86/BM95 tick vaccines is based on the development of antigenspecific antibodies in immunized hosts that interact and subsequently affect the biological function of the targeted antigen within the tick tissues, impairing tick feeding on the immunized hosts (7) (8) (9) . The application of the BM86/BM95-based vaccines results in reduction of the number, weight and reproductive capacity of engorging female ticks, resulting in a gradual reduction in tick infestations in subsequent generations (7) .
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The application of commercial vaccines for the control of cattle ticks demonstrated that tick vaccines also constitute an effective and environmentally sound approach for the control of tick-borne diseases (TBDs) (7) . However, despite recent advances in the identification and characterization of candidate tick vaccine antigens, new tick and pathogen derived protective antigens need to be identified to increase vaccine efficacy for the control of TBDs (6, 10) . Herein, we review some of the major approaches and strategies that are currently being used for the identification of protective antigens, as well as some future trends to develop improved tick vaccines.
FROM TICK BIOLOGY TO TICK VACCINES: A RATIONAL APPROACH
The rational approach towards discovery of promising vaccine candidates that will impair biological processes, stem from our knowledge of specific features in tick physiology that evolved during the adaptation of an ancestor mite to an obligatory blood-feeding lifestyle. Therefore, the processes associated with tick attachment to the host, followed by undisturbed feeding on the host, intracellular digestion of the large amount of ingested blood and finally, processing of the blood-meal into huge clutches of eggs laid by the engorged females. To date, this approach has offered a number of potential vulnerable targets (Achilles' heels) that could be affected by antibodies present in a vaccinated hosts. In this section we will enumerate the physiological processes that are targeted to date ( Figure 1 ) and link the research findings to our current understanding and approaches for the development of efficacious tick vaccines.
Tick attachment and on-host feeding
Blocking attachment of a tick to the host would be the ultimate goal, impairing not only tick feeding but also transmission of tick-borne pathogens. The process of attachment starts with the intrusion of the tick mouthpart (hypostome) into the host dermis, followed by anchoring of the tick by a cement cone that is mostly comprises of secreted glycine-rich proteins (11) .
Several cement cone antigens have been identified based on their immunogenicity. Screening of a cDNA expression library from Haemaphysalis longicornis females, with rabbit immune serum raised against tick saliva, resulted in the identification of a collagen-like protein P29 (12) and an unannotated
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protein HL 34 (that is rich in tyrosine and proline residue repeats) (13) . Immunization of rabbits with recombinant P29 caused about 50% mortality of H. longicornis larvae and nymphs (12) .
Immunization with recHL 34 reduced survival of both immature and adult H. longicornis stages. The appearance of ticks fed on vaccinated hosts point to impaired blood-meal uptake and digestion (13) .
Two vaccine candidates were identified from the cement cone of the African brown ear tick, Rhipicephalus appendiculatus. A highly immunogenic glycine-rich protein RIM 36 has the potential to be developed into a diagnostic marker for detection of cattle that have been exposed to feeding ticks, however its protective effect as a vaccine has not been assessed (14) . In contrast, a secreted 15 kDa protein called 64P seems to be invisible to the host immune response most likely given its similarity to the mammalian skin keratins (15) . The N-terminal portion of 64P displays similarity with the α2 chain of collagen type IV and exhibited very promising protection in animal trials when expressed as truncated 64P constructs (64TRPs) with GST as a fusion protein. The vaccine based on 64TRPs was reported to have a 'dual action' as tick feeding on immunized animals was primarily impaired at the skin feeding site, but cross-reaction of anti-64TRP antibodies with midgut antigenic epitopes also caused rupture of the tick midgut and death of engorged ticks (15) . In addition, several 64TRPs exhibited a cross-protective response against other tick species, namely Rhipicephalus sanguineus and Ixodes ricinus, underscoring their potential as a broad-spectrum tick vaccine (16).
Intriguingly, it was later demonstrated in a mouse model that vaccination with 64TRPs antigens protected mice against lethal transmission of tick-borne encephalitis virus (TBEV) by still unknown mechanisms (17) . However, these results were obtained in rodent models (guinea pigs and mice), with no evidence that it is effective in protection against tick infestation in natural hosts such as cattle.
Proteases and protease inhibitors at the tick-host interface
Tick saliva is an extremely rich cocktail of bioactive compounds that facilitates ixodid ticks to feed undisturbed on the host for several days. Our knowledge about the molecules produced by tick salivary glands (sialomes) increased dramatically during the past decade due to high-throughput transcriptome-based approaches (for review see, (18) . Most of the bioactive compounds modulating
Accepted Article
This article is protected by copyright. All rights reserved. host hemostasis, immune and inflammatory response are members of multigene families. This observation may lower the potential of individual saliva molecules as vaccine candidates given their extreme redundancy, but other possibilities to target these antigens during vaccination are discussed later in this paper. Despite the great redundancy of these proteins, some promising results have been reported for tick proteases and protease inhibitors involved in tick-host interactions.
Metalloproteases
The protective ability of Metis 1, a member of a putative metalloprotease family from salivary glands of I. ricinus (19) , was tested on rabbits immunized with recombinant Metis 1. Vaccination had no effect on tick attachment and mortality, but reduced the engorgement weight of I. ricinus females and their ability to lay eggs (20) . A slight increase in mortality (some 15%) was reported for H. longicornis nymphs and adults fed on rabbits vaccinated with recombinant metalloprotease HLMP1 (21) . Most recently, protective potential of the R. microplus metalloprotease BrRm-MP4 against R. microplus was tested in cattle trials. The overall efficacy of vaccination with recombinant BrRm-MP4 was 60%, mainly reducing the number of engorged ticks that completed feeding on immunized cattle (22) .
Protease inhibitors
A number of host defense reactions such as blood coagulation and complement activation are mediated by cascades of serine proteases (23) . Recombinant serine protease inhibitors (serpins) from several tick species have been examined as candidate vaccine targets. HLS2 from H. longicornis resulted in some 40% mortality of nymphs and adults fed on immunized rabbits (24, 25) . Four serpins, termed RAS-1-4 identified from R. appendiculatus (26) , were tested either as a mix of recombinant RAS-1 and RAS-2 (27) or as a cocktail composed of three antigens, RAS-3, RAS-4 and the immunedominant RIM36 (28) . Immunization of cattle with recombinant RAS-1 and RAS-2 reduced the number of engorged R. appendiculatus nymphs by 60% and increased mortality of adult males and females by 43% and 28%, respectively (27) . A combination of RAS-3, RAS-4 and RIM6 mainly affected the mortality of Theileria parva-infected females (~50%) (28) . The recombinant serpin, IRIS
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This article is protected by copyright. All rights reserved. from I. ricinus, exerted a significant protective immunity against nymphs and adults fed on vaccinated rabbits as displayed by increases in mortality (~ 30%), reduced weight of engorged ticks and prolonged feeding time. No effect was obtained for nymphs fed on vaccinated mice (29) .
Another group of tick protease inhibitors that are considered as possible candidate antigens are cystatins, that inhibit a variety of cysteine peptidases involved in modulation of host immunity and inflammation (30) . Sera from guinea pigs that were repeatedly exposed to tick infestation did not recognize sialostatin L2, a secreted immunomodulatory cystatin from Ixodes scapularis salivary glands. This antigen was subsequently termed a 'silent' antigen by the authors (31) . It does however need to be confirmed that this observation is not due to the antigen not being processed in antigen presenting cells, versus being secreted into an environment where immune-suppression is occurring due to tick saliva proteins. After all, a vast number of salivary gland proteins are not recognized by immune-sera, but they remain immunogenic upon vaccination. Nevertheless, feeding of I. scapularis nymphs on guinea pigs vaccinated with Sialostatin L2 was impaired as early rejection of the nymphs occurred as well as a reduction in the ability of remaining nymphs to imbibe blood (31) . Similar results were reported for the cystatin OmC2 from the soft tick, Ornithodoros moubata. Vaccination of mice with recombinant OmC2 significantly reduced the number of O. moubata first nymphal stage capable to complete feeding, resulting in increased post engorgement mortality (32) . As OmC2 is expressed in both the salivary gland and gut tissues of O. moubata, the authors speculated about a possible 'dual' action that impairs both feeding (via interfering with modulation of host immune response) and blood digestion (32) . More recently, identification and characterization of cystatins from other tick species, namely R. appendiculatus, R. microplus and Ixodes ovatus, were reported and the immunogenicity of corresponding recombinants tested as a first step towards their assessment as tick vaccine candidates (33) (34) (35) .
Water balance
Osmoregulation and water balance play an extremely important role in tick physiology as a fully engorged ixodid female tick can imbibe 200-300 times her own weight of host blood. The blood meal is concentrated in the gut with about 70% of the fluid being returned to the host via salivation (11, 36) . Therefore, water channels (aquaporins), present another rational target for vaccine development (37, 38) . The function of aquaporin was examined in I. ricinus by RNAi silencing of an aquaporin termed IrAQP1, resulting in 50% weight reduction of semi-engorged females that fed for 5 days.
Vaccination experiments remain to be performed for IrAQP1 (39) . Three aquaporins have been identified in the cattle tick R. microplus, and the vaccination potential of RmAQP1 was recently tested. Two independent pen trials (conducted in Brazil using Holstein-Friesian calves vaccinated with Pichia-expressed recombinant RmAQP1) exerted a high efficacy with 75% and 68% decrease respectively, in the number of adult ticks that completed feeding (40) . This result promotes RmAQP1 among the most promising vaccine candidates that should be further tested against cattle ticks in different geographic regions. More recently, stage and tissue expression profile and functional assessment by RNAi was reported for R. microplus aquaporin 2 (RmAQP2) (41) . RmAQP2 was found predominantly expressed in the salivary glands of semi-engorged females, and RNAi-mediated silencing resulted in a minor increase of the body weight of engorged females, pointing towards impairment of the osmoregulatory system. No vaccination effect with recombinant RmAQP2 has been reported to date.
Blood digestion
Blood meal processing occurs intracellularly within the digestive cells of the tick gut epithelium (11) and is performed by an orchestrated network of acidic peptidases comprising aspartic endopeptidases of the cathepsin D-type, cysteine endo-and exopeptidases of the papain-type (cathepsin L, B a C) and asparaginyl endopeptidases of the legumain-type (for review see (42)). This multi-enzyme digestive apparatus may seem to offer multiple potential antigens for efficient tick control, as suggested by the results of RNAi-mediated silencing of individual peptidases in several tick species (42) (43) (44) . However,
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to our knowledge, no successful vaccination experiment using a recombinant tick digestive enzyme has been reported to this end. Experimental vaccination of rabbits with a cocktail of recombinant cathepsins D, B, L, C and legumain from I. ricinus have been performed (45) . Despite high antibody titres against all of the recombinant antigens, only a slight increase in the mortality of I. ricinus females was observed in two of the three vaccinated rabbits. Currently, the potential of targeting multiple tick digestive peptidases by vaccination is limited given the high redundancy of the system, as previously demonstrated by specific inhibition of a subset of enzymes (46) . The possibility of targeting unique protein-protein interaction sites that may be more evolutionary conserved, is discussed later in this paper.
Heme and iron metabolism
Ticks have to cope with an excess of toxic heme and iron-derived metabolites from their blood meal.
The majority of heme is detoxified via its accumulation in organelles called hemosomes (47) of which only a small portion is used for tick's own metabolic demands as they are not capable of heme biosynthesis (48, 49) . The non-heme iron is sequestered intracellularly by ferritin 1 (Fer1), which is related to mammalian heavy-chain ferritins (50) . Their expression was shown to be posttranscriptionally regulated by an iron-responsive protein (IRP) (51) . Transport of non-heme iron from the tick gut to peripheral tissues is mediated by a secreted ferritin 2 protein (Fer2) that is distinct from tick ferritin 1 and mammalian ferritins (51) . The critical functions of tick ferritins in tick development and reproduction was demonstrated by RNAi-mediated silencing in I. ricinus (51) and H. longicornis (52, 53) . To date, much emphasis has been placed on tick Fer2 as it displays other desired attributes expected from an ideal concealed antigen, including: (i) not being present in the mammalian host; (ii) it is encoded by a single gene (no redundancy problem); (iii) it is expressed in the gut and therefore can come into contact with antibodies taken up by a bloodmeal from a vaccinated host, and (iv) it was shown to be highly immunogenic as a recombinant protein. In the first pilot experiments, vaccination of rabbits with recombinant Fer2 from I. ricinus substantially reduced tick infestation, weight of engorged females and their fertility with an overall efficacy of 98% (54) . In the same study, vaccination of cattle with recombinant Fer2 from R. microplus was reported to exert comparable
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Detoxification
Glutathione S-transferases (GSTs) from numerous parasites have been shown to play an important role in metabolic detoxification of xenobiotics, reactive oxygen species, heme and other toxic compounds, and as such present as a promising antigens for anti-parasitic vaccines (57, 58) . The protective potential of one such GST was examined using H. longicornis GST in cattle trials against R. microplus infestations (59). Given its cross-reactivity with other tick proteins, three out of four calves immunized with recombinant H. longicornis GST displayed some 50% reduction of engorged R. microplus adults.
Mating
The ability of ixodid females to initiate and complete the rapid engorgement phase of feeding is determined by their mating status. An engorgement factor that is passed from males to females during copulation was identified in Amblyoma hebraeum and termed voraxin (60) . It is composed of two unrelated peptides tagged AHEFα and AHEFβ of 16.1 kDa and 11.6 kDa, respectively. During vaccination trials in rabbits using a mixture of recombinant AHEFα and AHEFβ, only 25% of
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This article is protected by copyright. All rights reserved. normally mated A. hebraeum females were capable to fully engorge (60) . The potential of voraxin as a vaccine candidate was also evaluated against R. appendiculatus. Immunization of rabbits with recombinant voraxin α reduced the weight of engorged R. appendiculatus ticks by some 40% and also significantly impaired subsequent oviposition and larval hatching efficacy (61) .
Vitellogenesis and feritility
Impairment of vitellogenesis, embryogenesis and fertility by vaccination would be meaningful especially to control the population of one-host ticks such as R. microplus. Three enzymes involved in vitellogenin processing in R. microplus eggs have been identified and characterized to date. These include two aspartic peptidases, the Boophilus yolk pro-cathepsin (BYC) (62) and tick-heme binding aspartic peptidase (THAP) (63) , as well as a cathepsin L-like vitellogenin degrading cysteine endopeptidase (VTDCE) (64) . Bovine immunization was performed with native or recombinant BYC and VTDCE and the individual enzymes conferred only limited protection (some 25%) in overall efficacy (65) (66) (67) (68) . A combination of recombinant BYC and VTDCE and the previously mentioned GST from H. longicornis was evaluated as a cocktail vaccine in field conditions (69) . The number of semi-engorged females fed on the vaccinated cattle was reduced by about 50%, which seems to correlate with increased body weight gain in the vaccinated calves. This desired result further underscores the potential of multi-antigenic vaccines that might be capable to provide protection against ticks, and maybe also against the diseases they transmit.
REVERSE GENETICS APPROACH TO TICK VACCINES Tick genomic and sequence resources
Innovations in genome sequencing technologies have progressed the fields of reverse genetics and reverse vaccinology. Fewer genome projects have been developed for tick species due to their large genome sizes and the presence of dense repetitive regions. For example the genome sizes for I. scapularis and R. microplus were estimated at 2.1 Gb and 7.1 Gb respectively, with repetitive sequences occurring in a mixture of long and short period interspersions with 65-80% of the DNA
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Introduction to reverse genetics and applications to tick research
Forward genetics methods in eukaryotes have been used for more than 100 years to identify the gene(s) responsible for a particular phenotype, reviewed by Hardy et al. 2010 (79) . Reverse genetics consists of modifying the activity of a target gene to determine the phenotypic consequences.
Modifications to the genome are implemented by random chemical or insertional mutagenesis (e.g. transposons or retroviruses), or specifically using homologous recombination of a target gene (79) .
Other approaches targeting mRNA include morpholino antisense oligonucleotides and RNA interference (RNAi). RNAi has shown to be efficient in post transcriptional gene silencing using
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This article is protected by copyright. All rights reserved. exogenous or endogenous double stranded RNAs to knockdown specific transcripts (80) . For reverse genetics approaches, ideally the whole genome sequence is required in order to screen and predict the specificity of these knockdown treatments. In addition, genome sequencing has identified genes with unassigned functions. Assigning functions to these genes can be achieved by predicting subcellular localizations of gene products and by describing the phenotypes associated with their disruption (79).
Thus essentially high-throughput reverse genetics approaches are major tools in the post-genomic era.
A challenge with tick sequence analysis is the presence of a large number of genes whose functions are both unknown and unpredicted. These have been called 'orphan genes' which lack detectable sequence homology to genes in pre-existing databases (81) . For ticks, the most exploited reverse genetic approach has been RNAi (82) . 
Predictive algorithms for reverse vaccinology based tick vaccine candidate identification
Reverse vaccinology (RV) is defined as the screening of all open reading frames that a particular pathogen can express at any time followed by the screening for protective immunity as the 'rate limiting' step (87) . RV has so far been successful for the development of novel anti-bacterial vaccines with relatively small genomes in comparison to ectoparasites such as ticks (88) . With the completion of the I. scapularis genome, this provides an opportunity to develop a tick specific RV approach.
Approaches developed to predict vaccine antigens in ticks to date have not been undertaken using
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complete whole genome data. One study has used a B cell epitope prediction program (BCPREDS) to examine I. scapularis salivary proteins, however in vivo confirmation of the immunogenicity of these proteins was not demonstrated (89) . In addition, 24 hour fed I. scapularis tick saliva proteins were expressed using phage display and panned using antibodies to identify immunogenic proteins which could affect early feeding events including pathogen transmission, with no further testing reported (90) . A reverse vaccinology approach for soft ticks has been described as a concept paper only (91) .
The most researched tick species in terms of reverse vaccinology approaches has focused on the identification of vaccine candidates to protect against the cattle tick R. microplus species complex (including R. australis and specific clades of R. microplus and R. annulatus) (92), Table 2 . These ticks collectively vector babesiosis and anaplasmosis to susceptible cattle across cattle populations worldwide causing widespread losses (93, 94) . One approach mined the BmGI EST database available in 2007 and sequences from subtraction library experiments (86, 95) 
for specific Pfam database (96) signatures of putative antigenic proteins (97). Localization of the Pfam identified 400
ESTs included qRT-PCR analysis of different tick stages and organs collected from susceptible and resistant breeds of cattle and secretion predictions (SignalP), followed by the prediction of linear B cell binding epitopes using Bepipred (97, 98) . Antibodies produced against peptides recognized by tick resistant breeds of cattle were fed to semi-engorged female ticks in vitro (99) , and the corresponding peptides of the antibodies causing damage to ticks fed in vitro are currently being tested in cattle vaccine trials (97) . Another approach was based on a 'systems biology' analysis of transcriptome datasets and RNAi screening of potential candidates identifying an aquaporin protein found to be protective against R. annulatus and R. microplus challenge at 68% and 75% respectively (40, 100) . A third approach utilized the screening of the same BmGI EST database (86) using a custom microarray to screen different stages and organs of ticks. Functional annotations were undertaken prior to analysis using VaxiJen, which was developed to predict protective antigens of bacterial, viral and tumor origin (101) . Mouse antisera were used to pre-screen the putative candidates, which are currently being tested in cattle vaccine trials.
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This article is protected by copyright. All rights reserved. Many predictive tools have been developed to predict protein domains, secretion, transmembrane helices, GPI anchor, cellular localization and immune binding epitopes (104, 105) . There is a lack of ectoparasite specific tools for immuno-informatics analyses that have been tested or confirmed, with most tools reported to date developed based on bacterial and viral antigen discovery.
RV tick research approaches have also been limited by the absence of fully annotated tick genomes.
In addition, it is predicted that ticks have ~20,000 coding genes compared to ~3,000 (average) for bacteria. For bacteria, the comparison of multiple genomes (pan-genomics) have been recently added to RV pipelines to improve the robustness of antigen predictions (106) . Perhaps the future for tick vaccines will be the analysis of several genomes within and between species, to develop novel generic globally applicable tick vaccines. As genome sequencing technologies continuously improve, there are many options to consider for the future of tick vaccine development.
VACCINOMICS APPROACH TO TICK VACCINES
The challenge of developing improved vaccines against ticks and transmitted pathogens arises from the need to understand the complex molecular relationship between vertebrate hosts, ticks and pathogens which requires a systems biology approach that will allow the integrated analysis of metabolomics, transcriptomics, proteomics and other omics data for discovery of key pathways and molecules that mediate ticks-host-pathogen interactions. A vaccinomics approach could then be used to identify and fully characterize candidate protective antigens in different tick and pathogen species and validate vaccine formulations.
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Towards an integrated systems biology approach for tick vaccine development
Vaccinomics in this article refers to a holistic approach based on the use of genome-scale or omics technologies and bioinformatics in a systems biology approach for the development of nextgeneration vaccines (107) . The scientific principle underlying a systems biology approach to tick vaccine development is that ticks, hosts and pathogens have evolved molecular interactions that affect their survival and life cycle and this co-evolution involves genetic traits of the tick vectors, vertebrate hosts and pathogens. Vaccinomics is therefore seen as translational research, in which basic biological information on tick-host-pathogen interactions translates into the identification and subsequent evaluation of new vaccines. The pipeline and the methods proposed for tick vaccinomics were described recently (107, 108) (Figure 2 ).
The systems biology approach to the characterization of the molecular mechanisms that mediate tickhost-pathogen interactions identifies host/tick response and infection-transmission factors and will likely provide new targets for the control of tick infestations and/or pathogen infection and transmission (107) . Omics data integration should be followed by the identification of candidate protective antigens using a combination of different screening platforms to formulate and test vaccines in controlled pen trials and under field conditions (107) . Finally, the biological function and protective mechanisms elicited by vaccination should be characterized to provide additional information to design improved vaccines based on the combination of antigens with different functions to produce a synergistic effect upon vaccination (107) . The integration of omics databases for the identification of candidate protective antigens and the characterization of the immune mechanisms by which protective and non-protective responses to vaccines are generated are the major challenges in vaccinomics (107, 109) . Recent results using the Ixodes scapularis-host-Anaplasma phagocytophilum model illustrated the possibilities of these new technologies for the identification of key molecules and pathways involved in tick-host-pathogen interactions.
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Characterization of I. scapularis-host-A. phagocytophilum interactions

Transcriptomics and proteomics have been used for the characterization of I. scapularis-host-
A. phagocytophilum molecular interactions (18, 110, 111) . However, only recently the integration of additional datasets from metabolomics studies has been applied to the study of the I. scapularis-A. phagocytophilum interface (112) (113) (114) (115) (116) . The results of these analyses showed that A. phagocytophilum has evolved common molecular mechanisms to establish infection in tick vectors and vertebrate hosts (111) . These strategies include, but are not limited to, remodeling of the cytoskeleton, inhibition of cell apoptosis, manipulation of the immune response and the use of rickettsial proteins for infection and manipulation of tick and host gene expression (111) .
Vaccinomics approach for the identification of candidate tick protective antigens
For the proof of concept of the vaccinomics approach in ticks, a pipeline was designed based on proteins identified as involved in tick-pathogen interactions (107) . These proteins were selected as (119, 121, 122) . Then, in vitro capillary feeding was used to characterize their potential as antigens for the control of both cattle tick infestations and infection with A. marginale and B. bigemina (123) . Recombinant proteins were produced in Escherichia coli, purified and used to generate antibodies in rabbits. Purified rabbit polyclonal antibodies were added to uninfected or infected bovine blood to capillary-feed female R. microplus ticks. Capillary-fed ticks ingested antibodies added to the blood meal and a reduction in tick weight and/or oviposition was
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shown when compared to controls fed with blood alone (123) . However, no effect was observed on pathogen DNA levels in capillary fed ticks (123) . Nevertheless, these results together with previous results of functional studies by RNAi suggested that these proteins are promising vaccine antigens for the control of R. microplus infestations and infection with A. marginale and B. bigemina and supported the conduction of vaccine trials to validate these antigens (9) . Vaccination studies showed that vaccination with Silk and Subolesin, but not Trospa, reduced tick infestations and oviposition with respect to ticks fed on placebo-treated control cattle (124) . Furthermore, the results also showed that vaccination with Trospa and Subolesin reduced B. bigemina DNA levels in ticks while vaccination with Silk and Subolesin resulted in lower A. marginale DNA levels when compared to ticks fed on placebo control cattle (124) .
These results prove the validity of the vaccinomics approach to select protective antigens and show that vaccines using tick proteins involved in vector-pathogen interactions could be used for the dual control of tick infestations and pathogen infection. Remarkably, vaccination with Subolesin has shown an effect on the reduction of infestations by different ectoparasites and infection by different pathogens, therefore suggesting the possibility of developing vaccines for the control of multiple ectoparasites and infection/transmission of vector-borne pathogens (6) . Additionally, vaccinomics approach also results in the identification of pathogen-derived candidate protective antigens (116) . In this way, the combination of tick-derived with pathogen-derived antigens might results in more effective vaccines for the control of tick-borne diseases (6) .
INSIGHT FROM TICK PROTEIN EVOLUTION: TARGETING OF BINDING SPECIFIC EPITOPES (PROTEIN-PROTEIN INTERACTIONS) AND CONSERVED METABOLIC PATHWAYS
From a previous section of this paper describing the genomes sizes and repetitive nature of tick genomes, one is faced with questions pertaining to the origin(s) and significance of these large tick genomes and its impact on vaccine design. Leading studies from the group of Ben J Mans, have provided significant evidence for not only gene duplication leading to protein superfamilies, but also
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evidence that at least one genome duplication event occurred for ticks (125) (126) (127) . Evidence is growing on how rapid ticks can adapt to new climates, host species and challenges set by the use of acaricides, stressing their ability to acquire novel properties and functions within a short period of time. The adaptability of parasitic organisms has been ascribed to various factors including gene duplication, molecular chaperones, antigenic variation, polymorphisms, molecular mimicry, rapid turnover of surface molecules and gene disruption to name but a few (128) (129) (130) (131) (132) (133) . In ticks, gene duplications are most likely one of the strongest driving forces (125-128, 131, 133) . Therefore, our understandings of tick evolution, protein structure and function are vital in the search of new and improved tick vaccines. Furthermore, current data indicates that hard and soft ticks adapted independently and that the large protein families seem to be lineage specific expansions that occurred after their divergence.
This strongly suggests that a universal tick vaccine is non-viable and that focus should be placed on finding targets within subsets of closely related tick genera or even species. Cautions should thus be placed on extrapolating the protective abilities of a specific antigen between tick species, as was seen in the case of Bm86 vaccines (134) (135) (136) (137) (138) (139) and a vast number of antigens that failed to protect against different tick species across different hosts (as summarized in (140) .
Evaluation of all animal vaccine trials done to date indicate that single antigens display only some 40-60% protection under controlled conditions (140) . From experience, we know that these levels of protection will be greatly reduced under field conditions. This should stress the need to develop combinatorial tick vaccines and to expand our ideas on what a "targetable" genome may be in ticks.
For example, a proteome's complexity arises not only from the proteins three-dimensional structure (lower level information), but also from its functional interactions (higher level). This suggests an organized modularity for a proteome with connections to regulators, mediators and adaptors, all opening up a huge new complexity for therapeutic intervention.
We are entering an era where our understanding of how ticks evade vaccination and immune responses with their highly repetitive genomes, and how to formulate our vaccines to ensure that protective eiptopes remain accessible is vital. To date, only two examples of promising combinatorial vaccines are known, that of BM86 and subolesin (6, 107) and the peptide vaccine derived from a
This article is protected by copyright. All rights reserved. The true mechanism underlying the protective ability of the latter combination, as well as the reverse vaccinology-derived combination remains to be elucidated.
Protein-protein interactions (PPIs) and Metabolic Pathways
It is well known that protein sequences are more conserved than their coding nucleotide sequences, and that protein folds are more conserved than the amino acid sequences encoding them. Even more 
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This article is protected by copyright. All rights reserved. mechanism(s) used by ticks to overcome Bm86 vaccination are available, indicating that homologous Bm86 coding areas are expressed in R. appendiculatus (155) . No characterization of proteins that cross-react with immune sera (as is the case with sera raised against subolesin that show significant cross-reactivity) has been attempted. If one considers gene duplications in tick genomes, tick proteins may well make use of "misleading" surfaces with immunogenic epitopes, which will not necessarily be protective epitopes. This raises questions to the number of antigens that failed in animal trials and are being discarded as potential vaccine candidates
In ticks, only a single yeast two-hybrid study has been conducted, resulting in the identification of binding-partners of subolesin (121) . Since then, additional cDNA libraries have been cloned into various two-hybrid bait and prey plasmids, resulting in the identification of additional protein-protein interactions in R. microplus (patents pending). The protective ability of these protein-protein interacting antigens is currently being evaluated in cattle vaccine trials. Recently, surface plasmon resonance was used to confirm the protein-protein interaction between boophilin from R. microplus and thrombin (156) . In combination with the available crystal structure data (157) , this opens an exciting era to evaluate the use of protein binding epitopes as vaccines and to screen peptide and chemical libraries for small molecules or peptides capable of disrupting the protein-protein interactions between boophilin and thrombin.
With regards to PPIs involved in vector-pathogen-mammalian host interphases, the Borrelia burgdorferi field (causative agent of Lyme disease) is setting the trend with interactions described for BB0323 and BB0323 (158, 159) as well as OspA and CD40 (160) . Additional targets of interest include the tetratricopeptide repeat domain of BB0238 (161) and La7 (162) . Currently, interactomes of tick tissues of interest for vaccination as well as the tick-pathogen and tick-host interphases remains unexplored. Since most tick proteins are not annotatable using standard computational tools, the use of in silico method to predict PPIs will may of limited use and we may have to rely on classical techniques such as two-hybrid, pull down assays, anti-tag mediated co-immunoprecipitation, peptide
arrays, large scale co-immunoprecipitation studies and mass spectrometry to initiate the field. For predicting pathogen-host interactions, in silico methods may prove valuable, as supporting large datasets are available to be used as scaffolds (146, (163) (164) (165) (166) .
In addition to PPIs, another strategy to improve current vaccines involves the simultaneous targeting of antigens that function within a conserved metabolic pathway that occur in related tick species. In ticks, this has been evaluated to some extend by targeting gut proteins involved in tick digestion (as described in this paper). In 2015, a study by van Zyl et al. attempted to identify transcripts involved in metabolic pathways that are conserved in both R. microplus and R. decoloratus gut tissue. Chisquare analysis revealed that genes involved in lipid transport and metabolism are significantly overrepresented in both species (167) . Since then, the data was subjected to metabolic pathway analysis and key antigens selected, produced using recombinant E. coli and shown to be immunogenic. Vaccine trials using these combinatorial antigens are in process. In conclusion, RNAseq and DNA microarray analyses have identified tick proteins involved in a number of metabolic pathways all of which remains to be evaluated for PPIs and possible combinatorial vaccines targeting conserved metabolic pathways.
CONCLUSIONS AND FUTURE DIRECTIONS
Tick vaccines to date focused on targeting important biological processes (predominantly tick attachment and digestion) with the use of single antigens. Although these studies provided much needed insight into tick biology, it failed to provide full protection against tick infestations. Based on our growing knowledge of tick genome complexity and protein superfamilies, we are entering a new era that will require of us to understand the mechanism used by ticks to overcome changes in their environments (such as in the presence of vaccines or acaricides) and to expand our knowledge on the "targetable" genome of ticks. In this regard, reverse vaccinology, protein-protein interactions (especially those occurring across tick species) as well as systems biology used in vaccinomics will be vital.
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Studies on ticks and the tick-host-pathogen interactions suggest that a combination of pathogenderived ligands and/or tick/host receptors and other tick protective antigens will be needed in vaccines (6) . In this way, the vaccine containing vector and pathogen-derived antigens may protect vertebrate hosts against tick infestations and pathogen infection while also decreasing pathogen transmission and therefore the risk of disease in humans and animals. 
This article is protected by copyright. All rights reserved. (171, 172) Larvae and female salivary glands Illumina ~over 27,000 transcripts (173) Ixodes scapularis Nymphs and female midguts and salivary glands Illumina 17,503 transcripts (114) ISE6 cells Illumina 37,990 transcripts (115) 
Rhipicephalus haemaphysaloides
Unfed and fed female salivary glands Illumina/Solexa 25,113 transcripts; cysteine proteases upregulated in feeding ticks (174) Rhipicephalus Larvae, nymph, EST sanger CattleTickBase - (74) 
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Species
Species Reverse genetics approaches Data or vaccine output
Reference
Ixodes scapularis
Linear predictions of B-cell epitopes in salivary proteins (BCPREDS)
Not tested (89) Phage display of 24h tick saliva expressed genes screened using antibodies 182 contigs identified, No further testing (90) Ornithodoros soft ticks Secreted salivary proteins and concealed mid-gut antigens shown to be critical to the function of the tick; low copy number gene; and shared conserved epitopes among several tick species Review paper (91) 
Rhipicephalus (Boophilus) microplus
Gene discovery (EST library, subtraction libraries, microarray analysis, CattleTickBase), Bepipred predictions of linear Bcell epitopes, qRT-PCR On-going (97) 
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screening, predicted SignalP and localisation screening, anti-B cell peptide antibody in vitro tick feeding EST library, DNA microarrays, membrane and secreted proteins, VaxiJen, mouse antiserum screening
On-going (101) Systems biology, CattleTickBase, RNA interference screening, in silico antigenicity 75% protection (40) 
